Promethium Advisors »

Merck & Co shares owned by Promethium Advisors

Quarter-by-quarter ownership of Merck & Co (MRK) shares owned by Promethium Advisors from 13F filings

Historical chart of Promethium Advisors investment in Merck & Co

Tip: Access up to 7 years of quarterly data

All positions including Merck & Co held by Promethium Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merck & Co by Promethium Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.0M 8.9k 114.33

More positions owned by Promethium Advisors

Apple (AAPL)
Thomson Reuters Corp. (TRI)
Pfizer (PFE)
Bristol Myers Squibb (BMY)
Broadstone Net Lease (BNL)
T. Rowe Price (TROW)
Texas Pacific Land Corp (TPL)
Alphabet Cap Stk Cl A (GOOGL)
Danaher Corporation (DHR)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Cme (CME)
Ishares Tr U.s. Tech Etf (IYW)
Johnson & Johnson (JNJ)
Spdr Ser Tr Bloomberg 3-12 M (BILS)

View all positions for Promethium Advisors

Top funds holding Merck & Co

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Geode Capital Management
Morgan Stanley
Bank of America Corporation
Northern Trust
Jpmorgan Chase & Co
T. Rowe Price Associates
Deutsche Bank Aktiengesellschaft
Charles Schwab Investment Management
Bank of New York Mellon
Royal Bank of Canada
Amundi

View all funds holding Merck & Co